BLOODPAC Publications Featured May 12, 2026 Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based ctDNA Assays Version 2.0 May 12, 2026 Read more → May 12, 2026 January 21, 2026 Generic Protocols for Analytical Validation of Tumor-Informed Circulating Tumor DNA Assays for Molecular Residual Disease: BLOODPAC’s MRD Analytical Validation Working Group Consensus Recommendation January 21, 2026 Read more → January 21, 2026 January 9, 2026 Lexicon for Clonal Hematopoiesis in Liquid Biopsy January 9, 2026 Read more → January 9, 2026 October 6, 2025 Analytical Validation of Blood-Derived Tumor Mutation Burden (bTMB) Assays: A Joint Consensus Recommendation of the BLOODPAC bTMB Analytical Validation Working Group October 6, 2025 Read more → October 6, 2025 August 28, 2025 BLOODPAC’s Collaborations with European Union Liquid Biopsy Initiatives August 28, 2025 Read more → August 28, 2025 June 27, 2025 Minimum Technical Preanalytical, Patient, and Clinical Context Data Elements for Cerebrospinal Fluid Liquid Biopsy: Recommendations for Public Database Submissions June 27, 2025 Read more → June 27, 2025 April 23, 2025 Recommended Clinical Context and Patient Context Data Elements for Liquid Biopsy Data Submitted to Data Repositories and Data Commons April 23, 2025 Read more → April 23, 2025 April 21, 2025 Navigating Complexity: Perspectives on Risk Assessment in the Era of New Blood-based Tests for Early Cancer Detection April 21, 2025 Read more → April 21, 2025 March 14, 2025 Establishing a Common Lexicon for Circulating Tumor DNA Analysis and Molecular Residual Disease: Insights From the BLOODPAC Consortium March 14, 2025 Read more → March 14, 2025 August 29, 2024 Lexicon for blood-based early detection and screening: BLOODPAC consensus document August 29, 2024 Read more → August 29, 2024 August 23, 2024 Towards Preanalytical Best Practices for Liquid Biopsy Studies: A BLOODPAC Landscape Analysis August 23, 2024 Read more → August 23, 2024 January 2, 2024 Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care January 2, 2024 Read more → January 2, 2024 February 22, 2023 Contrived Materials and a Data Set for the Evaluation of Liquid Biopsy Tests February 22, 2023 Read more → February 22, 2023 October 17, 2022 BLOODPAC: Collaborating to chart a path towards blood-based screening for early cancer detection October 17, 2022 Read more → October 17, 2022 August 10, 2022 Creating Standards for Liquid Biopsies: the BLOODPAC Experience August 10, 2022 Read more → August 10, 2022 April 21, 2021 The BloodPAC Data Commons for Liquid Biopsy Data April 21, 2021 Read more → April 21, 2021 September 2, 2020 FDA-Reviewed Validation Protocols for Liquid Biopsy September 2, 2020 Read more → September 2, 2020 April 9, 2020 Three types of COVID-19 tests needed for return to normalcy April 9, 2020 Read more → April 9, 2020 April 1, 2020 Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases April 1, 2020 Read more → April 1, 2020 March 16, 2018 Getting past the bad blood of Theranos through collaboration March 16, 2018 Read more → March 16, 2018 February 12, 2018 Initial Release of Open Data February 12, 2018 Read more → February 12, 2018 February 10, 2017 Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium February 10, 2017 Read more → February 10, 2017
